SEQSTER and Praxis expand collaboration to expedite CNS disorder trials
SEQSTER has announced the expansion of its partnership with Praxis Precision Medicines to expedite clinical trials in central nervous system…
All articles by Salong Debbarma
Salong Debbarma
-
-
Arcutis reports positive topline data in Zoryve trial for infant AD
Arcutis has reported positive topline data from the INTEGUMENT-INFANT Phase II trialassessing Zoryve (roflumilast) cream 0.05% in infants aged three…
-
Jumo Health introduces clinical trial recruitment system
Jumo Health has launched PRISM, a clinical trial recruitment, enrolment, and retention system targeting persistent failures in research. The system…
-
ALX Oncology announces Phase Ib/II trial results for breast cancer
ALX Oncology has announced new data from a Phase Ib/II clinical trial of its cluster of differentiation 47 (CD47)-inhibitor, evorpacept,…
-
SK bioscience begins international Phase I/II trial for GBP511 vaccine
SK bioscience has initiated an international Phase I/II study in Australia for GBP511, a universal sarbecovirus vaccine candidate. The trial…
-
Ascletis reports positive results in Phase III denifanstat trial for acne
Ascletis Pharma has announced positive top line results from its Phase III open-label trial assessing the long-term safety of denifanstat…
-
Life Bio receives FDA approval for ER-100 clinical trial
Life Biosciences (Life Bio) has received US Food and Drug Administration (FDA) approval for its investigational new drug (IND) application,…
-
Ardelyx begins patient dosing in Phase III trial for CIC
Ardelyx has dosed the first patient in the ACCEL (ten-03-301) Phase III clinical trial evaluating Ibsrela (tenapanor) to treat chronic…
-
Roche reports positive top line Phase II data for CT-388 in obesity
Roche has reported positive top line results from its Phase II trial in obesity, where once-weekly subcutaneous injection of CT-388…
-
Arrowhead begins dosing in Phase I/IIa trial for hyperlipidaemia
Arrowhead Pharmaceuticals has dosed the first participants in its Phase I/IIa clinical trial of ARO-DIMER-PA, an investigational dual functional RNA…